Dynamic Risk Model for the Medical Treatment of Graves’ Hyperthyroidism according to Treatment Duration
Endocrinology and Metabolism · 31.08.2024 · 39 (4) · 579-589
DOI: 10.3803/enm.2024.1918 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology and Metabolism, erschienen am 31.08.2024. Verfasst von Meihua Jin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea. Hauptthemen laut MEDLINE: Graves Disease, Antithyroid Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Asan Institute for Life Sciences, Asan Medical Center.
Abstract (Originalsprache)
Background
Changes in thyrotropin receptor antibody (TRAb) levels are associated with the clinical outcomes of Graves’ hyperthyroidism. However, the effects of the patterns of TRAb changes on patient prognosis according to the treatment duration of antithyroid drugs (ATDs) are not well established.
Methods
In this retrospective cohort study, 1,235 patients with Graves’ hyperthyroidism who were treated with ATDs for more than 12 months were included. Patients were divided into two groups according to treatment duration: group 1 (12–24 months) and group 2 (>24 months). Risk prediction models comprising age, sex, and either TRAb levels at ATD withdrawal (model A) or patterns of TRAb changes (model B) were compared.
Results
The median treatment duration in groups 1 (n=667, 54%) and 2 (n=568, 46%) was 17.3 and 37.1 months, respectively. The recurrence rate was significantly higher in group 2 (47.9%) than in group 1 (41.4%, P=0.025). Group 2 had significantly more goiter, thyroid eye disease, and fluctuating and smoldering type of TRAb pattern compared with group 1 (all P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Förderung
- Asan Institute for Life Sciences, Asan Medical Center
Zitieren
APA
Jin, M., Kim, C. A., Jeon, M. J., Kim, W. B., Kim, T. Y., & Kim, W. G. (2024). Dynamic Risk Model for the Medical Treatment of Graves’ Hyperthyroidism according to Treatment Duration. Endocrinology and Metabolism, 39(4), 579-589. https://doi.org/10.3803/enm.2024.1918
Vancouver
Jin M, Kim CA, Jeon MJ, Kim WB, Kim TY, Kim WG. Dynamic Risk Model for the Medical Treatment of Graves’ Hyperthyroidism according to Treatment Duration. Endocrinology and Metabolism. 2024;39(4):579-589. doi:10.3803/enm.2024.1918
BibTeX
@article{Jin2024,
author = {Jin, Meihua and Kim, Chae A and Jeon, Min Ji and Kim, Won Bae and Kim, Tae Yong and Kim, Won Gu},
title = {Dynamic Risk Model for the Medical Treatment of Graves’ Hyperthyroidism according to Treatment Duration},
journal = {Endocrinology and Metabolism},
year = {2024},
volume = {39},
number = {4},
pages = {579--589},
doi = {10.3803/enm.2024.1918}
}
EUVIMED